COVID-19 Impact on Global Prostate Cancer Market Size, Status and Forecast 2020-2026

August 2020 | 92 pages | ID: C7A7C92EA123EN
QYResearch

Abstracts

This report focuses on the global Prostate Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Astellas, Inc.
• AstraZeneca plc
• Johnson & Johnson
• Sanofi S.A
• Bristol Myers Squibb (BMS)
• Bayer AG

Market segment by Type, the product can be split into

• Hormone sensitive prostate cancer
• Hormone refractory prostate cancer

Market segment by Application, split into

• Chemotherapy
• Hormonal Therapy
• Targeted Therapy
• Immunotherapy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Prostate Cancer status, future forecast, growth opportunity, key market and key players.
• To present the Prostate Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Prostate Cancer are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Revenue
1.4 Market Analysis by Type
  1.4.1 Global Prostate Cancer Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Hormone sensitive prostate cancer
  1.4.3 Hormone refractory prostate cancer
1.5 Market by Application
  1.5.1 Global Prostate Cancer Market Share by Application: 2020 VS 2026
  1.5.2 Chemotherapy
  1.5.3 Hormonal Therapy
  1.5.4 Targeted Therapy
  1.5.5 Immunotherapy
1.6 Coronavirus Disease 2019 (Covid-19): Prostate Cancer Industry Impact
  1.6.1 How the Covid-19 is Affecting the Prostate Cancer Industry
    1.6.1.1 Prostate Cancer Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Prostate Cancer Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Prostate Cancer Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Prostate Cancer Market Perspective (2015-2026)
2.2 Prostate Cancer Growth Trends by Regions
  2.2.1 Prostate Cancer Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Prostate Cancer Historic Market Share by Regions (2015-2020)
  2.2.3 Prostate Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Prostate Cancer Market Growth Strategy
  2.3.6 Primary Interviews with Key Prostate Cancer Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Prostate Cancer Players by Market Size
  3.1.1 Global Top Prostate Cancer Players by Revenue (2015-2020)
  3.1.2 Global Prostate Cancer Revenue Market Share by Players (2015-2020)
  3.1.3 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Market Concentration Ratio
  3.2.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2019
3.3 Prostate Cancer Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Product Solution and Service
3.5 Date of Enter into Prostate Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Prostate Cancer Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Forecasted Market Size by Type (2021-2026)

5 PROSTATE CANCER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Prostate Cancer Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Prostate Cancer Market Size (2015-2020)
6.2 Prostate Cancer Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Prostate Cancer Market Size (2015-2020)
7.2 Prostate Cancer Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Market Size by Application (2015-2020)

8 CHINA

8.1 China Prostate Cancer Market Size (2015-2020)
8.2 Prostate Cancer Key Players in China (2019-2020)
8.3 China Prostate Cancer Market Size by Type (2015-2020)
8.4 China Prostate Cancer Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Prostate Cancer Market Size (2015-2020)
9.2 Prostate Cancer Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Prostate Cancer Market Size (2015-2020)
10.2 Prostate Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Market Size by Application (2015-2020)

11 INDIA

11.1 India Prostate Cancer Market Size (2015-2020)
11.2 Prostate Cancer Key Players in India (2019-2020)
11.3 India Prostate Cancer Market Size by Type (2015-2020)
11.4 India Prostate Cancer Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Prostate Cancer Market Size (2015-2020)
12.2 Prostate Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astellas, Inc.
  13.1.1 Astellas, Inc. Company Details
  13.1.2 Astellas, Inc. Business Overview and Its Total Revenue
  13.1.3 Astellas, Inc. Prostate Cancer Introduction
  13.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2015-2020))
  13.1.5 Astellas, Inc. Recent Development
13.2 AstraZeneca plc
  13.2.1 AstraZeneca plc Company Details
  13.2.2 AstraZeneca plc Business Overview and Its Total Revenue
  13.2.3 AstraZeneca plc Prostate Cancer Introduction
  13.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2015-2020)
  13.2.5 AstraZeneca plc Recent Development
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Details
  13.3.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.3.3 Johnson & Johnson Prostate Cancer Introduction
  13.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2015-2020)
  13.3.5 Johnson & Johnson Recent Development
13.4 Sanofi S.A
  13.4.1 Sanofi S.A Company Details
  13.4.2 Sanofi S.A Business Overview and Its Total Revenue
  13.4.3 Sanofi S.A Prostate Cancer Introduction
  13.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2015-2020)
  13.4.5 Sanofi S.A Recent Development
13.5 Bristol Myers Squibb (BMS)
  13.5.1 Bristol Myers Squibb (BMS) Company Details
  13.5.2 Bristol Myers Squibb (BMS) Business Overview and Its Total Revenue
  13.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction
  13.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2015-2020)
  13.5.5 Bristol Myers Squibb (BMS) Recent Development
13.6 Bayer AG
  13.6.1 Bayer AG Company Details
  13.6.2 Bayer AG Business Overview and Its Total Revenue
  13.6.3 Bayer AG Prostate Cancer Introduction
  13.6.4 Bayer AG Revenue in Prostate Cancer Business (2015-2020)
  13.6.5 Bayer AG Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Prostate Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Revenue
Table 3. Ranking of Global Top Prostate Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormone sensitive prostate cancer
Table 6. Key Players of Hormone refractory prostate cancer
Table 7. COVID-19 Impact Global Market: (Four Prostate Cancer Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Prostate Cancer Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Prostate Cancer Players to Combat Covid-19 Impact
Table 12. Global Prostate Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Prostate Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Prostate Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Prostate Cancer Market Share by Regions (2015-2020)
Table 16. Global Prostate Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Prostate Cancer Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Prostate Cancer Market Growth Strategy
Table 22. Main Points Interviewed from Key Prostate Cancer Players
Table 23. Global Prostate Cancer Revenue by Players (2015-2020) (Million US$)
Table 24. Global Prostate Cancer Market Share by Players (2015-2020)
Table 25. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer as of 2019)
Table 26. Global Prostate Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Prostate Cancer Product Solution and Service
Table 29. Date of Enter into Prostate Cancer Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 32. Global Prostate Cancer Market Size Share by Type (2015-2020)
Table 33. Global Prostate Cancer Revenue Market Share by Type (2021-2026)
Table 34. Global Prostate Cancer Market Size Share by Application (2015-2020)
Table 35. Global Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 36. Global Prostate Cancer Market Size Share by Application (2021-2026)
Table 37. North America Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Prostate Cancer Market Share (2019-2020)
Table 39. North America Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 40. North America Prostate Cancer Market Share by Type (2015-2020)
Table 41. North America Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 42. North America Prostate Cancer Market Share by Application (2015-2020)
Table 43. Europe Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Prostate Cancer Market Share (2019-2020)
Table 45. Europe Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Prostate Cancer Market Share by Type (2015-2020)
Table 47. Europe Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Prostate Cancer Market Share by Application (2015-2020)
Table 49. China Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 50. China Key Players Prostate Cancer Market Share (2019-2020)
Table 51. China Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 52. China Prostate Cancer Market Share by Type (2015-2020)
Table 53. China Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 54. China Prostate Cancer Market Share by Application (2015-2020)
Table 55. Japan Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Prostate Cancer Market Share (2019-2020)
Table 57. Japan Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Prostate Cancer Market Share by Type (2015-2020)
Table 59. Japan Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Prostate Cancer Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Prostate Cancer Market Share (2019-2020)
Table 63. Southeast Asia Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Prostate Cancer Market Share by Type (2015-2020)
Table 65. Southeast Asia Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Prostate Cancer Market Share by Application (2015-2020)
Table 67. India Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 68. India Key Players Prostate Cancer Market Share (2019-2020)
Table 69. India Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 70. India Prostate Cancer Market Share by Type (2015-2020)
Table 71. India Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 72. India Prostate Cancer Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Prostate Cancer Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Prostate Cancer Market Share (2019-2020)
Table 75. Central & South America Prostate Cancer Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Prostate Cancer Market Share by Type (2015-2020)
Table 77. Central & South America Prostate Cancer Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Prostate Cancer Market Share by Application (2015-2020)
Table 79. Astellas, Inc. Company Details
Table 80. Astellas, Inc. Business Overview
Table 81. Astellas, Inc. Product
Table 82. Astellas, Inc. Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 83. Astellas, Inc. Recent Development
Table 84. AstraZeneca plc Company Details
Table 85. AstraZeneca plc Business Overview
Table 86. AstraZeneca plc Product
Table 87. AstraZeneca plc Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 88. AstraZeneca plc Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Sanofi S.A Company Details
Table 95. Sanofi S.A Business Overview
Table 96. Sanofi S.A Product
Table 97. Sanofi S.A Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 98. Sanofi S.A Recent Development
Table 99. Bristol Myers Squibb (BMS) Company Details
Table 100. Bristol Myers Squibb (BMS) Business Overview
Table 101. Bristol Myers Squibb (BMS) Product
Table 102. Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 103. Bristol Myers Squibb (BMS) Recent Development
Table 104. Bayer AG Company Details
Table 105. Bayer AG Business Overview
Table 106. Bayer AG Product
Table 107. Bayer AG Revenue in Prostate Cancer Business (2015-2020) (Million US$)
Table 108. Bayer AG Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Prostate Cancer Market Share by Type: 2020 VS 2026
Figure 2. Hormone sensitive prostate cancer Features
Figure 3. Hormone refractory prostate cancer Features
Figure 4. Global Prostate Cancer Market Share by Application: 2020 VS 2026
Figure 5. Chemotherapy Case Studies
Figure 6. Hormonal Therapy Case Studies
Figure 7. Targeted Therapy Case Studies
Figure 8. Immunotherapy Case Studies
Figure 9. Prostate Cancer Report Years Considered
Figure 10. Global Prostate Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Prostate Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Prostate Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Prostate Cancer Market Share by Players in 2019
Figure 15. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Revenue in 2019
Figure 17. North America Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Prostate Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Astellas, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Astellas, Inc. Revenue Growth Rate in Prostate Cancer Business (2015-2020)
Figure 26. AstraZeneca plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Business (2015-2020)
Figure 28. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Business (2015-2020)
Figure 30. Sanofi S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Sanofi S.A Revenue Growth Rate in Prostate Cancer Business (2015-2020)
Figure 32. Bristol Myers Squibb (BMS) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Bristol Myers Squibb (BMS) Revenue Growth Rate in Prostate Cancer Business (2015-2020)
Figure 34. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bayer AG Revenue Growth Rate in Prostate Cancer Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed